Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by JULKUNEN, H.
Right arrow Articles by KOSKIMIES, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by JULKUNEN, H.
Right arrow Articles by KOSKIMIES, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 British Society for Rheumatology


research-article

MATERNAL HLA ANTIGENS AND ANTIBODIES TO SS-A/RO AND SS-B/LA. COMPARISON WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND PRIMARY SJÖGREN’S SYNDROME

H. JULKUNEN, M.-K. SIREN*, R. KAAJA{dagger}, P. KURKI{ddagger}, C. FRIMAN and S. KOSKIMIES*

Fourth Department of Medicine, Helsinki University Central Hospital Unioninkatu 38, 00170 Helsinki
*Finnish Red Cross Blood Transfusion Centre Kivihaantie 7, 00310 Helsinki
{dagger}Department of Obstetrics and Gynaecology, Helsinki University Central Hospital Haartmanninkatu 2, 00290 Helsinki
{ddagger}Department of Bacteriology and Immunology, Helsinki University Haartmanninkatu 3, 00290 Helsinki, Finland

Correspondence to: Correspondence to: H.Julkunen, Peijas Hospital, Sairaalakatu I, 04100, Vanatas, Finland.

To study the maternal immunogenetics in congenital heart block (CHB), 31 mothers of affected children were HLA typed for class I and II antigens, and the results were compared with the corresponding HLA types in 900 healthy controls, in 45 mothers with systemic lupus erythematosus (SLE) and in 21 mothers with primary SS who had healthy children. An enzyme-linked immunosorbent assay was used to study the autoantibody responses to the recombinant 52 and 60 kDa SS-A/Ro, and 48 kDa SS-B/La proteins, and to the affinity-purified SS-A/Ro and SS-B/La antigens. Mothers of children with CHB had HLA B8 and DR3 significantly more often than healthy controls [71 vs 20%; relative risk (RR) 9.8, P <0.00001 and 74 vs 23% RR 9.8, P <0.0001, respectively]. HLA B35 was protective (RR 0.1, P = 0.0029). Compared to controls with SLE, mothers of children with CHB were more often HLA DR3 and DQ2 positive (RR 4.1, P = 0.0057 and RR 3.1, P = 0.031, respectively), and compared to controls with primary SS less often HLA B15 positive (RR 0.1, P =0.010). In general, the HLA antigen profile in mothers of children with CHB was more closely related to primary SS than to SLE. Levels of antibodies to all three SS-A/Ro antigens were significantly higher in mothers of children with CHB than in controls with SLE and primary SS (P = 0.0001–-0.0014). With regard to SS-B/La, the autoantibody responses were similar (P = 0.32-0.66). HLA B8, DR3, DQ2 and heterozygosity for DQ1/DQ2 were strongly associated with all three assays for antibodies to SS-A/Ro (P =0.0001–0.018). The corresponding associations with antibodies to SS7-B/La were weaker (P = 0.0076–1.0). The common immunogenetic background of the mother for having a child with CHB is the presence of HLA antigens B8, DR3 and DQ2 associated with high levels of antibodies to SS7-A/Ro. Mothers of children with CHB are genetically more closely related to patients with primary SS than to patients with SLE.

KEY WORDS: Congenital heart block, HLA antigens, SS-A/Ro antibodies, SS-B/La antibodies, Systemic lupus erythematosus, Primary Sjögren's syndrome


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.